rs1012282

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001854.4(COL11A1):​c.3168+41T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.26 in 1,571,308 control chromosomes in the GnomAD database, including 55,383 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6451 hom., cov: 32)
Exomes 𝑓: 0.26 ( 48932 hom. )

Consequence

COL11A1
NM_001854.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.49

Publications

10 publications found
Variant links:
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
COL11A1 Gene-Disease associations (from GenCC):
  • Marshall syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • Stickler syndrome type 2
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Orphanet, Genomics England PanelApp
  • fibrochondrogenesis 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal dominant 37
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 1-102961825-A-G is Benign according to our data. Variant chr1-102961825-A-G is described in ClinVar as Benign. ClinVar VariationId is 258456.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.376 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A1NM_001854.4 linkc.3168+41T>C intron_variant Intron 41 of 66 ENST00000370096.9 NP_001845.3 P12107-1Q59HB5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A1ENST00000370096.9 linkc.3168+41T>C intron_variant Intron 41 of 66 1 NM_001854.4 ENSP00000359114.3 P12107-1

Frequencies

GnomAD3 genomes
AF:
0.283
AC:
43023
AN:
152016
Hom.:
6440
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.381
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.251
Gnomad ASJ
AF:
0.221
Gnomad EAS
AF:
0.0864
Gnomad SAS
AF:
0.161
Gnomad FIN
AF:
0.271
Gnomad MID
AF:
0.307
Gnomad NFE
AF:
0.263
Gnomad OTH
AF:
0.261
GnomAD2 exomes
AF:
0.248
AC:
60776
AN:
244704
AF XY:
0.243
show subpopulations
Gnomad AFR exome
AF:
0.387
Gnomad AMR exome
AF:
0.271
Gnomad ASJ exome
AF:
0.229
Gnomad EAS exome
AF:
0.0884
Gnomad FIN exome
AF:
0.272
Gnomad NFE exome
AF:
0.267
Gnomad OTH exome
AF:
0.253
GnomAD4 exome
AF:
0.258
AC:
365859
AN:
1419174
Hom.:
48932
Cov.:
24
AF XY:
0.255
AC XY:
180607
AN XY:
708108
show subpopulations
African (AFR)
AF:
0.386
AC:
12652
AN:
32752
American (AMR)
AF:
0.272
AC:
11972
AN:
44080
Ashkenazi Jewish (ASJ)
AF:
0.230
AC:
5927
AN:
25732
East Asian (EAS)
AF:
0.0745
AC:
2945
AN:
39512
South Asian (SAS)
AF:
0.168
AC:
14180
AN:
84574
European-Finnish (FIN)
AF:
0.271
AC:
14398
AN:
53052
Middle Eastern (MID)
AF:
0.292
AC:
1656
AN:
5672
European-Non Finnish (NFE)
AF:
0.267
AC:
286961
AN:
1074876
Other (OTH)
AF:
0.257
AC:
15168
AN:
58924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
12487
24975
37462
49950
62437
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9436
18872
28308
37744
47180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.283
AC:
43081
AN:
152134
Hom.:
6451
Cov.:
32
AF XY:
0.280
AC XY:
20829
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.381
AC:
15803
AN:
41502
American (AMR)
AF:
0.250
AC:
3821
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.221
AC:
769
AN:
3472
East Asian (EAS)
AF:
0.0864
AC:
447
AN:
5172
South Asian (SAS)
AF:
0.162
AC:
782
AN:
4832
European-Finnish (FIN)
AF:
0.271
AC:
2868
AN:
10602
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.263
AC:
17848
AN:
67978
Other (OTH)
AF:
0.260
AC:
548
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1541
3081
4622
6162
7703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.276
Hom.:
10822
Bravo
AF:
0.288
Asia WGS
AF:
0.166
AC:
576
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hearing loss, autosomal dominant 37 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Marshall syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibrochondrogenesis 1 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Stickler syndrome type 2 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.2
DANN
Benign
0.36
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1012282; hg19: chr1-103427381; API